Global Artificial Intelligence in Drug Discovery market size was valued at $473.4 million in 2019 and is expected to grow at a CAGR of 28% from 2021 to 2027. Momentum for Reducing Drug Discovery Costs Production in recent years is expected to increase the demand for artificial intelligence (AI) platforms in the field of drug discovery.
A full report of Artificial Intelligence (AI) in Drug Discovery Market available at https://www.orionmarketreports.com/cancer-biomarker-market/11654/
Artificial Intelligence (AI) in Drug Discovery Market: Segmentation
By Offering
• Software
• Services
By Technology
• Machine Learning
• Others Technologies
By Application
• Immuno-Oncology
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Metabolic Diseases
• Other Applications
By End User
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Research Centers And Academic & Government Institutes
Market Key Players
• IBM Watson
• Exscientia
• GNS Healthcare
• Alphabet (DeepMind)
• Benevolent AI
• BioSymetrics
• Euretos
• Berg Health
• Atomwise
• Insitro
• Cyclica
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)